Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Sullivan

Showing results (1191-1200 of 1,317) with videos related to

Pageof 132
Sort By:
Cancer Treatment Reports|February 1, 1976
Role of DTIC (NSC-45388) in the chemotherapy of sarcomasJ A Gottlieb, R S Benjamin, L H Baker, et al.
Journal of Medicinal Chemistry|May 28, 2004
Synthesis and structure-activity relationships of a novel series of tricyclic dihydropyridine-based KATP openers that potently inhibit bladder contractions in vitroWilliam A Carroll, Konstantinos A Agrios, Robert J Altenbach, et al.
Journal of Medicinal Chemistry|September 27, 2008
Rotationally constrained 2,4-diamino-5,6-disubstituted pyrimidines: a new class of histamine H4 receptor antagonists with improved druglikeness and in vivo efficacy in pain and inflammation modelsMarlon D Cowart, Robert J Altenbach, Huaqing Liu, et al.
Nature|February 25, 2021
Spatiotemporal dissection of the cell cycle with single-cell proteogenomicsDiana Mahdessian, Anthony J Cesnik, Christian Gnann, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 25, 2018
Chemical feedbacks weaken the wintertime response of particulate sulfate and nitrate to emissions reductions over the eastern United StatesViral Shah, Lyatt Jaeglé, Joel A Thornton, et al.
CNS Drug Reviews|June 5, 2004
ABT-089: pharmacological properties of a neuronal nicotinic acetylcholine receptor agonist for the potential treatment of cognitive disordersLynne E Rueter, David J Anderson, Clark A Briggs, et al.
Cancer Discovery|August 21, 2014
Brain tumor cells in circulation are enriched for mesenchymal gene expressionJames P Sullivan, Brian V Nahed, Marissa W Madden, et al.
BMJ Open|March 13, 2025
Improving Outcomes in Mental Health (IOMH)-an Australian longitudinal clinical study of families with children with neurodevelopmental problems: cohort profileDana E Galligan, Leanne Payne, Daniel P Sullivan, et al.
Biorxiv : the Preprint Server for Biology|December 18, 2023
Integrated omics analysis unveils a DNA damage response to neurogenic injuryAli Hashemi Gheinani, Bryan S Sack, Alex Bigger-Allen, et al.
The Journal of Clinical Investigation|October 4, 2017
CD56bright NK cells exhibit potent antitumor responses following IL-15 primingJulia A Wagner, Maximillian Rosario, Rizwan Romee, et al.
Pageof 132

Showing results (1191-1200 of 1,317) with videos related to

Sort By:
Pageof 132
Cancer Treatment Reports|February 1, 1976
Role of DTIC (NSC-45388) in the chemotherapy of sarcomasJ A Gottlieb, R S Benjamin, L H Baker, et al.
Journal of Medicinal Chemistry|May 28, 2004
Synthesis and structure-activity relationships of a novel series of tricyclic dihydropyridine-based KATP openers that potently inhibit bladder contractions in vitroWilliam A Carroll, Konstantinos A Agrios, Robert J Altenbach, et al.
Journal of Medicinal Chemistry|September 27, 2008
Rotationally constrained 2,4-diamino-5,6-disubstituted pyrimidines: a new class of histamine H4 receptor antagonists with improved druglikeness and in vivo efficacy in pain and inflammation modelsMarlon D Cowart, Robert J Altenbach, Huaqing Liu, et al.
Nature|February 25, 2021
Spatiotemporal dissection of the cell cycle with single-cell proteogenomicsDiana Mahdessian, Anthony J Cesnik, Christian Gnann, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 25, 2018
Chemical feedbacks weaken the wintertime response of particulate sulfate and nitrate to emissions reductions over the eastern United StatesViral Shah, Lyatt Jaeglé, Joel A Thornton, et al.
CNS Drug Reviews|June 5, 2004
ABT-089: pharmacological properties of a neuronal nicotinic acetylcholine receptor agonist for the potential treatment of cognitive disordersLynne E Rueter, David J Anderson, Clark A Briggs, et al.
Cancer Discovery|August 21, 2014
Brain tumor cells in circulation are enriched for mesenchymal gene expressionJames P Sullivan, Brian V Nahed, Marissa W Madden, et al.
BMJ Open|March 13, 2025
Improving Outcomes in Mental Health (IOMH)-an Australian longitudinal clinical study of families with children with neurodevelopmental problems: cohort profileDana E Galligan, Leanne Payne, Daniel P Sullivan, et al.
Biorxiv : the Preprint Server for Biology|December 18, 2023
Integrated omics analysis unveils a DNA damage response to neurogenic injuryAli Hashemi Gheinani, Bryan S Sack, Alex Bigger-Allen, et al.
The Journal of Clinical Investigation|October 4, 2017
CD56bright NK cells exhibit potent antitumor responses following IL-15 primingJulia A Wagner, Maximillian Rosario, Rizwan Romee, et al.
Pageof 132